Last updated on December 2013

Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients


Brief description of study

The present proof of concept study addresses the following specific aims: The general objectives of this work are: 1. To increase and maintain the functional beta-cell mass after islet transplantation under a condition of low-dose tacrolimus 2. To co-investigate the potential of alternative sites for encapsulated beta-cells

Detailed Study Description

1. Aim 1: To increase functional beta cell mass by adding rituximab at first implantation 2. Aim 2: To increase functional beta cell mass by adding basilixumab at second implantation 3. Aim 3: To assess the influence of down-tapering the tacrolimus dose during posttransplant years 2-5 on these data, on metabolic control, on the prevalence of hypoglycemia and on safety parameters. 4. Aim 4: To investigate the potential of the peritoneum and omentum as an alternative site for encapsulated beta-cells. 5. Aim 5: To investigate the potential of the brachioradial muscle as an alternative site for encapsulated beta-cells.

Clinical Study Identifier: NCT00798785

Contact Investigators or Research Sites near you

Start Over

Hopital Erasme

Brussel, Belgium
7.22miles
  Connect »

University Hospital Brussels

Brussels, Belgium
8.97miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.